Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2025-12-24 @ 11:43 PM
NCT ID: NCT04764851
Eligibility Criteria: Inclusion Criteria: * Male subjects or female subjects of non-childbearing potential * ≥18 and \<55 years of age at the time of consent * BMI \>18.5 and \<30 kg/m2 and a weight of ≥50 kg for males or ≥45 kg for females * Sexually active males must use a double barrier method of contraception during the study and for at least 90 days after the last dose of study drug * Male subjects must be willing not to donate sperm until 90 days following the last study drug administration Exclusion Criteria: * Personal or family History of significant medical illness * Clinically significant abnormalities on screening tests/exams * History of or significant risk of committing suicide * Donation of plasma within 7 days prior to dosing * Donation or significant loss of blood within 30 days prior to the first dosing * Major surgery within 3 months or minor surgery within 1 month prior to admission * Use of prohibited prescription, over-the-counter medications or natural health products * Alcohol-based products 24 hours prior to admission * Female subjects who are currently pregnant or lactating * Positive pregnancy test * Use of tobacco or nicotine products within 3 months prior to Screening * Significant alcohol consumption * History of drug abuse within the previous 2 years, or a positive drug screen * History of allergy to study medications * Undergoing abrupt discontinuation of alcohol or sedatives * Not suitable for study in the opinion of the Principal Investigator
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT04764851
Study Brief:
Protocol Section: NCT04764851